Kyron.bio

Kyron.bio

Private
ParisHealthcare & Life Scienceshttps://www.kyron.bio/

Last Round

Grant

May 28, 2025

Total Funding Raised

$3.96M

Company Overview

Kyron.bio is a biotechnology company that has developed a bioproduction platform to produce cheap and novel biopharmaceuticals by leveraging patentable technology that boosts the effectiveness and yield of therapeutic proteins.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Pharma Supply Chain, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

glycan engineeringsynthetic biologybioproduction platformSynBioengineered cell linesantibody therapeuticsglycosylation controlcell line engineeringtechbioplatform biotechtherapeutic proteinsbiomanufacturingCHO cellsbiologics CMCbioprocessingprotein engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kyron.bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kyron.bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantMay 28, 2025

Kyron.bio Investors

Notable investors and investment history

InvestorRounds
Saras CapitalGrant
Verve VenturesGrant
HCVCGrant
Entrepreneurs FirstGrant, Pre Seed

Kyron.bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kyron.bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kyron.bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range10
Year Founded2022
Last FundingMay 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.